SINGAPORE (Nov 19): Healthcare provider Religare Health Trust is “fairly priced” at $0.97, with the firm’s expansionary outlook now included in its current valuation, DBS says in a note.

The research house also notes the firm will likely continue to deliver “decent organic growth.”

The bank says it is positive on expansion plans for the trust in India but doesn't see much new share price action as a result.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook